The directors of Fusen Pharmaceutical Company Limited do not recommend the payment of a dividend in respect of the six months ended 30 June 2022 (six months ended 30 June 2021: RMB 0.57 cents).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.18 HKD | 0.00% | -0.84% | -13.87% |
05-31 | Chinese Regulators Accept Fusen Pharmaceutical’s Drug Application | MT |
04-04 | Fusen Pharmaceutical's Type 2 Diabetes Drug Application Accepted by Chinese Regulator | MT |
1st Jan change | Capi. | |
---|---|---|
-13.87% | 112M | |
+19.64% | 43.3B | |
+21.25% | 22.22B | |
+18.92% | 15.43B | |
+20.14% | 14.48B | |
+53.19% | 12.72B | |
-0.05% | 6.79B | |
-11.11% | 6.71B | |
-8.87% | 5.73B | |
+14.68% | 5.5B |
- Stock Market
- Equities
- 1652 Stock
- News Fusen Pharmaceutical Company Limited
- Fusen Pharmaceutical Company Limited Does Not Recommend Dividend for the Six Months Ended June 30, 2022